Actavis, a foreign generic company, will enter the domestic market, followed after Teva and Alvogen
Another generic of a multinational brand is expected to enter the domestic market.
The company is the top U.S. generic company, Actavis. After taking over the pharmaceutical company specializing in cosmetic products, such as Botox, Allergan, last November, the company changed its company name to...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
